Skip to main content
. 2023 Oct 9;15(10):2435. doi: 10.3390/pharmaceutics15102435

Figure 7.

Figure 7

Biosafety evaluation and toxicity of mAb-TPCA-1@HCNPs: routine blood (AH) and blood biochemistry (IN) analyses of mice after 14 days of treatment with PBS and mAb-TPCA-1@HCNPs at a high dose of 100 mg/kg in healthy BALB/c mice; body weight of mice in 14 days after treatments as indicated (O).